INSIGHTS & ANALYTICS
Ariya turns research, analytics, and CI into decision-ready briefs with trade-offs and sources attached, so leadership works from your analysis instead of a diluted summary.
THE CHALLENGE
Your brief gets summarized in a meeting you weren't in — the nuance disappears.
By the time your analysis is needed, it's out of date, out of context, or out of the room.
Decisions happen in conversations. Your analysis lives in documents.
Ariya puts your intelligence in the room when the decision is made — structured, traceable, ready to act on.
HOW IT WORKS FOR YOUR TEAM
KNOWLEDGE CONSOLIDATION
Ariya connects your market research, competitive intelligence, medical publications, and field data into a single layer — organised by brand, market, and role. No more hunting across shared drives and agency portals.
DECISION STRUCTURING
Ariya structures the decision behind the question — trade-offs made explicit, conflicting signals surfaced, recommended action generated with confidence scoring and source traceability. Not a summary. A decision.
INSIGHT ACTIVATION
Ariya generates outputs stakeholders can act on directly — decision memos, executive briefs, PowerPoint-ready content. All sourced, on-brand, and compliance-flagged.
A DAY IN THE LIFE
INPUT
Market research, CI trackers, medical literature, and field data — structured by brand and market into one layer.
QUERY
Not just what the data says — but what it means for the decision at hand. Ariya structures the answer across all connected sources.
STRUCTURE
Conflicting signals flagged. Confidence scored. Sources attached. The logic is explicit and defensible.
OUTPUT
Decision memo, executive summary, or stakeholder email — generated from the same structured context. Compliant. On-brand. Traceable.
SEE IT IN CONTEXT
What is Theravexium Biologics doing around Oxymat in neurology, and what actions should we take?
Based on Q2 MR, how should we adjust digital engagement for Oxymat in the Trialists Segment?
What should we prioritize for Oxymat in the Trialists Segment based on the latest CI signals and Q2 MR insights?
We stopped producing decks and started producing decisions. Ariya changed how our insights team shows up in strategic conversations.
Head of Insights & Analytics, Small biopharmaceutical company focused on rare diseases
Trusted by pharma teams across Europe
The problem Ariya solves isn't insight quality — it's insight accessibility. Your analysis is only as valuable as its influence on the decisions being made. Ariya makes your existing insights available at the moment they're needed, structured for the decision at hand, not filed away for the next quarterly review.
Knowledge management tools store documents. BI platforms visualize data. Ariya structures decisions. It takes what you already have — research, data, competitive intelligence — and turns it into a recommended action with explicit trade-offs, confidence scoring, and source traceability. The output is a decision brief, not a dashboard.
Yes. Ariya connects to the sources your team already uses — market research reports, CI trackers, medical literature databases, field data exports, and CRM outputs. phamax leads the initial structuring and connection setup. No IT project required on your side.
Every Ariya output is grounded in and traceable to your source documents. The platform does not generate claims from general training data — it reasons within the knowledge base you define and validate. Your team reviews outputs before they are shared. Human override is built into the workflow.
Your team owns the knowledge base — what goes in, how it is organized, and what the platform is allowed to reason across. phamax sets up the infrastructure, leads onboarding, and supports ongoing structuring. Most insights leads find they need one to two hours per week to keep the knowledge layer current after the initial setup.
See Ariya in 30 minutes. No slides. A live demo on your context.